Details of the Drug Excipient
General Information of Drug Inactive Ingredient (DIG) (ID: E00402)
| DIG Name |
Aspartame
|
||||
|---|---|---|---|---|---|
| Synonyms |
aspartame; 22839-47-0; Nutrasweet; Asp-phe-ome; Asp-Phe methyl ester; Aspartam; Canderel; L-Aspartyl-L-phenylalanine methyl ester; Aspartamo; Aspartamum; Aspartylphenylalanine methyl ester; Sweet dipeptide; Dipeptide sweetener; Methyl aspartylphenylalanate; H-Asp-Phe-OMe; 1-Methyl N-L-alpha-aspartyl-L-phenylalanate; Tri-sweet; methyl L-alpha-aspartyl-L-phenylalaninate; UNII-Z0H242BBR1; Equal; 3-Amino-N-(alpha-methoxycarbonylphenethyl) succinamic acid; (S)-3-Amino-4-(((S)-1-methoxy-1-oxo-3-phenylpropan-2-yl)amino)-4-oxobutanoic acid; CHEBI:2877; N-L-alpha-Aspartyl-L-phenylalanine 1-methyl ester; 3-Amino-N-(alpha-carboxyphenethyl)succinamic acid N-methyl ester; SC-18862; MFCD00002724; (3S)-3-amino-4-[[(2S)-1-methoxy-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid; Z0H242BBR1; N-L-ALPHA-ASPARTYL L-PHENYLALANINE 1-METHYL ESTER; NCGC00091104-02; DSSTox_CID_107; E 951; (S)-3-amino-4-((S)-1-methoxy-1-oxo-3-phenylpropan-2-ylamino)-4-oxobutanoic acid; DSSTox_RID_75371; DSSTox_GSID_20107; Sanecta; N-L-alpha-Aspartyl-L-phenylalanine methyl ester; Aspartam [INN-French]; Aspartame, L,L-alpha-; Aspartamum [INN-Latin]; Aspartamo [INN-Spanish]; SMR000471870; CAS-22839-47-0; CCRIS 5456; L-Aspartyl-L-phenylalanine methyl ester, 98%; SC 18862; HSDB 3915; Methyl L-aspartyl-L-phenylalanine; EINECS 245-261-3; Methyl L-alpha-aspartyl-L-phenylalanate; Aminosweet; L-Phenylalanine, N-L-alpha-aspartyl-, 1-methyl ester; Palsweet Diet; Methyl N-L-alpha-aspartyl-L-phenylalaninate; 1-Methyl N-L-alpha-aspartyl-L-phenylalanine; Pal Sweet; Aspartame [USAN:INN:BAN:NF]; NCGC00095160-01; DF-OMe; Aspartame (NF/INN); N-(L-a-Aspartyl)-L-phenylalanine methyl ester; Spectrum2_001706; Spectrum3_001949; Epitope ID:164026; 3-Amino-N-(alpha-carboxyphenethyl)succinamic acid N-methyl ester, stereoisomer; SCHEMBL3636; Succinamic acid, 3-amino-N-(alpha-carboxyphenethyl)-, N-methyl ester, stereoisomer; BSPBio_003549; MLS001066421; MLS001306461; Aspartame, analytical standard; SPECTRUM1505306; L-Phenylalanine, L-alpha-aspartyl-, 2-methyl ester; SPBio_001692; CHEMBL171679; DTXSID0020107; Asp-Phe methyl ester, >=98%; KBio3_002839; aspartyl-phenylalanine methyl ester; HMS1922B16; HMS2093B05; HMS2233D15; Pharmakon1600-01505306; HY-B0361; ZINC1532132; Tox21_111080; Tox21_111459; Tox21_202315; Tox21_302965; CCG-39444; NSC758953; s2036; SBB006713; AKOS015920055; L-Aspartyl-L-phenylalanyl methyl ester; Tert-butylN-(3-formylphenyl)carbamate; Tox21_111080_1; AM84801; Aspartame 1000 microg/mL in Methanol; DB00168; MCULE-7493691716; NSC-758953; alpha-aspartyl-phenylalanine methyl ester; L-aspartyl-L-phenyl-alanine methyl ester; NCGC00091104-01; NCGC00091104-03; NCGC00091104-04; NCGC00091104-05; NCGC00095160-03; NCGC00256407-01; NCGC00259864-01; AC-12293; AS-13889; E951; L-Aspartyl-L-3-phenylalanine methyl ester; SBI-0206757.P001; AB0058040; Asp-Phe methyl ester, >=99.0% (HPLC); A0997; AM20060556; SW219179-1; alpha-L-Aspartyl-L-Phenylalanine Methyl Ester; L-Aspartyl-L-phenylalanine methyl ester, 96%; 39A470; A11698; C11045; D02381; M-4739; AB00376622_08; AB00376622_09; N-L-??-Aspartyl-L-phenylalanine 1-methyl ester; N-(L-alpha-Aspartyl)-L-phenylalanine methyl ester; Q182040; SR-05000001682; J-502447; SR-05000001682-1; BRD-K78841970-001-06-2; Aspartame, European Pharmacopoeia (EP) Reference Standard; Aspartame, United States Pharmacopeia (USP) Reference Standard; (S)-3-amino-n-((s)-1-methoxycarbonyl-2-phenyl-ethyl)-succinamic acid; Aspartame, Pharmaceutical Secondary Standard; Certified Reference Material; (3S)-3-{N-[(1S)-1-(methoxycarbonyl)-2-phenylethyl]carbamoyl}-3-aminopropanoic acid; (3S)-3-amino-3-{[(2S)-1-methoxy-1-oxo-3-phenylpropan-2-yl]carbamoyl}propanoic acid; 7421-84-3
|
||||
| DIG Function |
Flavoring agent
|
||||
| Formula |
C14H18N2O5
|
||||
| Canonical SMILES |
COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O)N
|
||||
| InChI |
1S/C14H18N2O5/c1-21-14(20)11(7-9-5-3-2-4-6-9)16-13(19)10(15)8-12(17)18/h2-6,10-11H,7-8,15H2,1H3,(H,16,19)(H,17,18)/t10-,11-/m0/s1
|
||||
| InChIKey |
IAOZJIPTCAWIRG-QWRGUYRKSA-N
|
||||
| Physicochemical Properties | Molecular Weight | 294.3 | Topological Polar Surface Area | 119 | |
| XlogP | -2.7 | Complexity | 380 | ||
| Heavy Atom Count | 21 | Rotatable Bond Count | 8 | ||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 6 | ||
Full List of Drug(s) Co-administrated with This DIG